In their study of transgenic mice, Ponticos et al. demonstrated the profibrotic effect of CTGF in pulmonary fibrosis and reported that CTGF may represent a target molecule in the treatment of diseases that progress with fibrosis.31 This evidence concerns the gene CCN2 and pulmonary fibrosis.